Let us help you "Get to Done"
We’ve been in your shoes. Let us help you find a better way.
The No Surprises Act (NSA) introduces new protections and a transparent framework for resolving out-of-network payment disputes, empowering health plans and providers to navigate these challenges via a multi-step process. The Independent Dispute Resolution (IDR) process, while vital for resolving out-of-network payment disputes under the No Surprises Act, comes with its own set of challenges:
Managed by the Departments of Health and Human Services, Labor, and the Treasury, this system supports fair billing practices while striving to foster collaboration between health plans and care providers.
To ensure a seamless experience, health plans and providers must adopt proactive strategies, such as streamlining communication workflows, standardizing templates, and implementing robust tracking systems to stay on top of deadlines and deliver timely responses.
When managing an influx of claim disputes, non-standard email notifications, and required actions based on varied deadlines with the focus on compliance and revenue cycle goals, it is best to reassess and redesign your NSA/IDR process.
Reviewing a difficult process requires a structured approach to identify inefficiencies, pinpoint root causes, and develop actionable solutions.
Here are the key assessment steps:
Trexin can help you navigate and overcome the varied challenges in the IDR process with results focused on process efficiency, submission compliance, and financial success.
Healthcare & Life Sciences | MedTech | Optimized Operations | Products & Distribution | Strategy & Innovation
Kenneth Beymer examines the new and updated state-level PFAS regulations beginning in 2025.
Data & Artificial Intelligence (AI) | Healthcare & Life Sciences | Optimized Operations | Technology
Asim Jeelani provides information on the risks and implications of CMS Final Rule 0057 as well as effective strategies to mitigate the risks.
Healthcare & Life Sciences | MedTech | Optimized Operations
Bo Youman unpacks the fragility of medical supply chains and shares ways organizations can effectively prevent or mitigate disruption.